Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
    5.
    发明授权
    Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline 有权
    1-氧代-2-(2,6-二氧代哌啶-3-基)-4-氨基异二氢吲哚的药物组合物

    公开(公告)号:US07119106B2

    公开(公告)日:2006-10-10

    申请号:US10337602

    申请日:2003-01-06

    IPC分类号: A61K31/445 C07D401/04

    CPC分类号: C07D401/04

    摘要: Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNFα in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafuoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3 -methylpiperidin-3-yl)-4-aminoisoindoline.

    摘要翻译: 取代的2-(2,6-二氧代哌啶-3-基)苯二酰亚胺和1-氧代-2-(2,6-二氧代哌啶-3-基)异吲哚啉降低哺乳动物TNFalpha的水平。 典型的实施方案是1-氧代-2-(2,6-二氧代-3-甲基哌啶-3-基)-4,5,6,7-四氟异吲哚啉和1,3-二氧代-2-(2,6-二氧代 - 3-甲基哌啶-3-基)-4-氨基异吲哚啉。